Literature DB >> 29909855

Effects of intermittent pneumatic compression treatment on clinical outcomes and biochemical markers in patients at low mobility with lower limb edema.

Mirko Tessari1, Veronica Tisato2, Erika Rimondi2, Paolo Zamboni3, Anna Maria Malagoni3.   

Abstract

OBJECTIVE: We aimed to evaluate the effects of intermittent pneumatic compression (IPC) in patients at low mobility with leg edema.
METHODS: A pilot, two-arm, randomized controlled clinical trial was performed. Fifty patients (age, 58.4 ± 9 years; male, 14), randomly allocated to a group (IPC) undergoing 1 month (n = 29) of an in-home cycle of IPC and to a control (C) group (n = 21), were studied. Leg edema was evaluated by measuring subcutaneous thickness (high-resolution ultrasound) and circumferences (metric tape), both assessed at different levels of the lower limbs, and volume (water plethysmography). Ankle range of motion (ROM, goniometer), quality of life (QoL) by the 36-Item Short Form Health Survey, and a pool of plasma inflammatory markers were also evaluated.
RESULTS: Edema significantly decreased in the IPC group (for all outcome measures, P < .0001), whereas it significantly increased in the C group (P < .0001). Ankle ROM was significantly enhanced in the IPC group (dorsiflexion, P < .0001; plantar flexion, P = .002) and remained stable in the C group. QoL showed an improvement in the IPC group, particularly significant for the general health subscale (P = .004), whereas no changes were highlighted in the C group. The two groups exhibited different trends and variations for some plasma inflammatory markers, mainly for granulocyte colony-stimulating factor.
CONCLUSIONS: In a sample of patients at reduced mobility with leg edema, IPC treatment was effective in reducing the edema, improving the ankle ROM, and determining a positive impact on QoL together with a slight modulation of some plasma inflammatory markers.
Copyright © 2018 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Compression devices; Edema; Intermittent pneumatic; Lymphatic disease; Mobility limitation; Venous insufficiency

Mesh:

Substances:

Year:  2018        PMID: 29909855     DOI: 10.1016/j.jvsv.2018.01.019

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  3 in total

1.  Perioperative and posttraumatic anti-edematous decongestive device-based negative pressure treatment for anti-edematous swelling treatment of the lower extremity - a prospective quality study.

Authors:  Klaus Dresing; Ann-Christin Fischer; Wolfgang Lehmann; Dominik Saul; Christopher Spering
Journal:  Int J Burns Trauma       Date:  2021-06-15

2.  Daily use of a muscle pump activator device reduces duration of hospitalization and improves early graft outcomes post-kidney transplantation: A randomized controlled trial.

Authors:  Wen Xie; Max A Levine; Shahid Aquil; Katharine Pacoli; Rafid Al-Ogaili; Patrick P Luke; Alp Sener
Journal:  Can Urol Assoc J       Date:  2021-02       Impact factor: 1.862

3.  Limb edema in critically ill patients: Comparing intermittent compression and elevation.

Authors:  Mehdi Ahmadinejad; Farideh Razban; Yunes Jahani; Faezeh Heravi
Journal:  Int Wound J       Date:  2022-01-06       Impact factor: 3.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.